A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects

Trial Profile

A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-0980 Following Single Oral Dose Administration in Healthy Postmenopausal Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jun 2016

At a glance

  • Drugs Apitolisib (Primary)
  • Indications Breast cancer; Endometrial cancer; Non-Hodgkin's lymphoma; Renal cancer; Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Genentech
  • Most Recent Events

    • 29 Jul 2013 Actual end date changed from Mar 2012 to Jan 2012, as reported by ClinicalTrials.gov.
    • 30 Aug 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
    • 10 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top